Filtros de búsqueda

Lista de obras de Kimme Hyrich

15.3 Agreement between parent and adolescent assessment of disability, pain and well-being: results from the Childhood Arthritis Prospective Study (CAPS).

artículo científico publicado en 2008

2010 ACR/EULAR classification criteria for rheumatoid arthritis predict increased mortality in patients with early arthritis: results from the Norfolk Arthritis Register

artículo científico publicado en 2013

2017 EULAR recommendations for a core data set to support observational research and clinical care in rheumatoid arthritis

artículo científico publicado en 2018

A Common Functional Ability Score for Young People with Juvenile Idiopathic Arthritis

scientific article published on 14 April 2020

A Threshold Hazard Model for Estimating Serious Infection Risk Following Anti-Tumor Necrosis Factor Therapy in Rheumatoid Arthritis Patients

article

A UK study: vocational experiences of young adults with juvenile idiopathic arthritis

scientific article published on 06 August 2019

A comparison of patient characteristics and outcomes in selected European and U.S. rheumatoid arthritis registries

artículo científico publicado en 2010

A survey of national and multi-national registries and cohort studies in juvenile idiopathic arthritis: challenges and opportunities

artículo científico publicado en 2017

Abatacept in the long-term treatment of rheumatoid arthritis ⬇️

artículo científico publicado el 1 de marzo de 2012

Agreement between proxy and adolescent assessment of disability, pain, and well-being in juvenile idiopathic arthritis

artículo científico publicado en 2011

Anti-TNF therapies and pregnancy: outcome of 130 pregnancies in the British Society for Rheumatology Biologics Register

artículo científico publicado en 2011

Anti-TNF therapy in women with rheumatoid arthritis with a history of carcinoma in situ of the cervix: Table 1

artículo científico publicado en 2012

Anti-TNF therapy is associated with an increased risk of serious infections in patients with rheumatoid arthritis especially in the first 6 months of treatment: updated results from the British Society for Rheumatology Biologics Register with specia

artículo científico publicado en 2010

Anti-tumor necrosis factor-alpha agents for rheumatoid arthritis: assessing longterm safety

scientific article published on 01 May 2006

Anti-tumour necrosis factor alpha therapy in rheumatoid arthritis: an update on safety

artículo científico publicado en 2004

Are patients with RA at increased risk of malignancy?

artículo científico publicado en 2008

Assessing the safety of biologic therapies in rheumatoid arthritis: the challenges of study design.

artículo científico publicado en 2005

Assessing the safety of new drugs during pregnancy

artículo científico publicado en 2018

Association Between Ischemic Stroke and Tumor Necrosis Factor Inhibitor Therapy in Patients With Rheumatoid Arthritis.

artículo científico publicado en 2016

Association between IL2RA and juvenile idiopathic arthritis (JIA) disease severity at first presentation to paediatric rheumatology: results from the Childhood Arthritis Prospective Study (CAPS).

artículo científico publicado en 2008

Association between anti-tumour necrosis factor treatment response and genetic variants within the TLR and NF B signalling pathways

article

Association between duration of symptoms and severity of disease at first presentation to paediatric rheumatology: results from the Childhood Arthritis Prospective Study

artículo científico publicado en 2008

Association of HLA-DRB1 haplotypes with rheumatoid arthritis severity, mortality, and treatment response

artículo científico publicado en 2015

Association of a complement receptor 1 gene variant with baseline erythrocyte sedimentation rate levels in patients starting anti-TNF therapy in a UK rheumatoid arthritis cohort: results from the Biologics in Rheumatoid Arthritis Genetics and Genomi

artículo científico publicado en 2013

Association of rheumatoid factor and anti-cyclic citrullinated peptide positivity, but not carriage of shared epitope or PTPN22 susceptibility variants, with anti-tumour necrosis factor response in rheumatoid arthritis

artículo científico publicado en 2008

Association of the tumour necrosis factor-308 variant with differential response to anti-TNF agents in the treatment of rheumatoid arthritis

article

Associations of baseline use of biologic or targeted synthetic DMARDs with COVID-19 severity in rheumatoid arthritis: Results from the COVID-19 Global Rheumatology Alliance physician registry

artículo científico publicado en 2021

BHPR research: qualitative * 1. Complex reasoning determines patients' perception of outcome following foot surgery in rheumatoid arhtritis

artículo científico publicado en 2012

BSR and BHPR guidelines on the use of rituximab in rheumatoid arthritis

artículo científico publicado en 2011

BSR and BHPR rheumatoid arthritis guidelines on eligibility criteria for the first biological therapy

artículo científico publicado en 2010

BSR and BHPR rheumatoid arthritis guidelines on safety of anti-TNF therapies

scholarly article by T. Ding et al published 12 September 2010 in Rheumatology

Baseline comorbidity levels in biologic and standard DMARD treated patients with rheumatoid arthritis: results from a national patient register

artículo científico publicado en 2005

Benefit of anti-TNF therapy in rheumatoid arthritis patients with moderate disease activity

artículo científico publicado en 2009

Biologic refractory disease in rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis ⬇️

scientific article published on 06 July 2018

Biologic therapies and pregnancy: the story so far

artículo científico publicado en 2013

Biologic therapy for rheumatoid arthritis: clinical efficacy and predictors of response

artículo científico publicado en 2009

Biologic treatment response among adults with juvenile idiopathic arthritis: results from the British Society for Rheumatology Biologics Register

artículo científico publicado en 2013

Biologics registers in RA: methodological aspects, current role and future applications ⬇️

artículo científico publicado en 2017

Biologics registers in rheumatoid arthritis

scholarly article by Rebecca Davies et al published May 2014 in Medicine

COVID-19 Global Rheumatology Alliance Registry, anti-IL-6 therapy, shared decision-making and patient outcomes. Response to: 'Correspondence on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from

artículo científico publicado en 2020

COVID-19 in Pregnant Women With Rheumatic Disease: Data From the COVID-19 Global Rheumatology Alliance

artículo científico publicado en 2021

Cervical screening uptake and rates of cervical dysplasia in the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

artículo científico publicado en 2020

Changes in disease characteristics and response rates among patients in the United Kingdom starting anti-tumour necrosis factor therapy for rheumatoid arthritis between 2001 and 2008.

artículo científico publicado en 2010

Changes in the illness perceptions of patients with rheumatoid arthritis over the first year of methotrexate therapy

artículo científico publicado en 2020

Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-reported registry

artículo científico publicado en 2020

Characteristics of difficult-to-treat rheumatoid arthritis: results of an international survey

artículo científico publicado en 2018

Clinical utility of random anti-tumour necrosis factor drug testing and measurement of anti-drug antibodies on long-term treatment response in rheumatoid arthritis.

artículo científico publicado en 2015

Comment on: Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register: reply

Common aspects of human and primate seronegative arthritis.

artículo científico publicado en 2004

Comparing Proxy, Adolescent, and Adult Assessments of Functional Ability in Adolescents With Juvenile Idiopathic Arthritis

scientific article published on 01 April 2020

Comparison of the response to infliximab or etanercept monotherapy with the response to cotherapy with methotrexate or another disease-modifying antirheumatic drug in patients with rheumatoid arthritis: Results from the British Society for Rheumatolo

article

Consistency and Utility of Data Items Across European Rheumatoid Arthritis Clinical Cohorts and Registers

artículo científico publicado en 2015

Correction: Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity

artículo científico publicado en 2020

Correlation of C-reactive protein haplotypes with serum C-reactive protein level and response to anti-tumor necrosis factor therapy in UK rheumatoid arthritis patients: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study S

artículo científico publicado en 2012

Depressive symptoms, pain and disability for adolescent patients with juvenile idiopathic arthritis: results from the Childhood Arthritis Prospective Study

artículo científico publicado en 2018

Detection and evaluation of a drug safety signal concerning pancreatic cancer: lessons from a joint approach of three European biologics registers

artículo científico publicado en 2010

Detection of anti-drug antibodies using a bridging ELISA compared with radioimmunoassay in adalimumab-treated rheumatoid arthritis patients with random drug levels. ⬇️

scientific article published on 25 August 2016

Different methods of balancing covariates leading to different effect estimates in the presence of effect modification

artículo científico publicado en 2009

Differential DNA methylation correlates with response to methotrexate in rheumatoid arthritis

artículo científico publicado en 2019

Differential Methylation as a Biomarker of Response to Etanercept in Patients With Rheumatoid Arthritis ⬇️

scientific article published on 27 January 2016

Disease activity and disability in children with juvenile idiopathic arthritis one year following presentation to paediatric rheumatology. Results from the Childhood Arthritis Prospective Study

artículo científico publicado en 2009

Does sex or ethnicity impact anti-tumour necrosis factor agent use in rheumatoid arthritis?

artículo científico publicado en 2016

Drug persistence, effectiveness and safety assessment of anti-TNF therapies in psoriatic arthritis

scientific article published on 06 January 2011

Drug-specific risk and characteristics of lupus and vasculitis-like events in patients with rheumatoid arthritis treated with TNFi: results from BSRBR-RA. ⬇️

artículo científico publicado en 2017

Drug-specific risk of tuberculosis in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register (BSRBR).

artículo científico publicado en 2009

Duration of etanercept treatment and reasons for discontinuation in a cohort of juvenile idiopathic arthritis patients.

artículo científico publicado en 2010

EULAR definition of difficult-to-treat rheumatoid arthritis

scientific article published on 01 October 2020

Early response to anti-TNF predicts long-term outcomes including sustained remission: an analysis of the BSRBR-RA

artículo científico publicado en 2019

Effect of anti-tumor necrosis factor on work disability

artículo científico publicado en 2007

Effectiveness and safety of TNF inhibitors in adults with juvenile idiopathic arthritis

artículo científico publicado en 2016

Effectiveness of Rituximab in Patients with Rheumatoid Arthritis: Observational Study from the British Society for Rheumatology Biologics Register

artículo científico publicado en 2011

Effects of switching between anti-TNF therapies on HAQ response in patients who do not respond to their first anti-TNF drug.

artículo científico publicado en 2008

Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register

artículo científico publicado en 2010

Efficacy and safety of anti-TNF therapies in psoriatic arthritis: an observational study from the British Society for Rheumatology Biologics Register.

artículo científico publicado en 2017

Efficacy of biologic therapy across individual juvenile idiopathic arthritis subtypes: A systematic review

artículo científico publicado en 2016

Evaluating the real-world benefits and risks of anti-tumor necrosis factor therapies

artículo científico publicado en 2013

Evidence for association of autoimmune genes with disabilty in juvenile idiopathic arthritis in a UK cohort

article

Evidence of NLRP3-inflammasome activation in rheumatoid arthritis (RA); genetic variants within the NLRP3-inflammasome complex in relation to susceptibility to RA and response to anti-TNF treatment

artículo científico publicado en 2013

Factors Associated With Sustained Remission in Rheumatoid Arthritis in Patients Treated With Anti-Tumor Necrosis Factor

artículo científico publicado en 2016

Factors associated with COVID-19-related death in people with rheumatic diseases: results from the COVID-19 Global Rheumatology Alliance physician-reported registry

artículo científico publicado en 2021

Factors associated with choice of biologic among children with Juvenile Idiopathic Arthritis: results from two UK paediatric biologic registers

artículo científico publicado en 2016

Factors associated with choice of first biologic among children with juvenile idiopathic arthritis: a combined analysis from two UK paediatric biologic registers.

artículo científico publicado en 2014

Factors associated with improvement in disease activity following initiation of etanercept in children and young people with Juvenile Idiopathic Arthritis: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort

artículo científico publicado en 2015

Frequency of biologic switching and the outcomes of switching in children and young people with juvenile idiopathic arthritis: a national cohort study

artículo científico publicado en 2020

Gender stratified adjustment of the DAS28-CRP improves inter-score agreement with the DAS28-ESR in rheumatoid arthritis

scientific article published on 01 May 2019

Genetic variants within the MAP kinase signalling network and anti-TNF treatment response in rheumatoid arthritis patients

artículo científico publicado en 2010

Genome-wide association study and gene expression analysis identifies CD84 as a predictor of response to etanercept therapy in rheumatoid arthritis

artículo científico publicado en 2013

Genome-wide association study of genetic predictors of anti-tumor necrosis factor treatment efficacy in rheumatoid arthritis identifies associations with polymorphisms at seven loci

artículo científico publicado en 2011

Genome-wide association study of response to tumour necrosis factor inhibitor therapy in rheumatoid arthritis ⬇️

article

Genotype at the sIL-6R A358C polymorphism does not influence response to anti-TNF therapy in patients with rheumatoid arthritis

article

Growth in children and adolescents with juvenile idiopathic arthritis over 2 years of treatment with etanercept: results from the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study

artículo científico publicado en 2015

Growth patterns in early juvenile idiopathic arthritis: Results from the Childhood Arthritis Prospective Study (CAPS).

artículo científico publicado en 2017

Harnessing repeated measurements of predictor variables for clinical risk prediction: a review of existing methods

artículo científico publicado en 2020

Heterogeneity of Anticitrullinated Peptide Antibodies and Response to Anti-Tumor Necrosis Factor Agents in Rheumatoid Arthritis ⬇️

artículo científico publicado el 1 de abril de 2012

High frequency of antidrug antibodies and association of random drug levels with efficacy in certolizumab pegol-treated patients with rheumatoid arthritis: results from the BRAGGSS cohort ⬇️

artículo científico publicado en 2016

How common is clinically inactive disease in a prospective cohort of patients with juvenile idiopathic arthritis? The importance of definition

artículo científico publicado en 2017

How common is remission in juvenile idiopathic arthritis: A systematic review

artículo científico publicado en 2017

Impact of TNF inhibitor therapy on joint replacement rates in rheumatoid arthritis: a matched cohort analysis of BSRBR-RA UK registry data.

artículo científico publicado en 2019

Impact of concomitant use of DMARDs on the persistence with anti-TNF therapies in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register

artículo científico publicado en 2011

Impact of inadequate adherence on response to subcutaneously administered anti-tumour necrosis factor drugs: results from the Biologics in Rheumatoid Arthritis Genetics and Genomics Study Syndicate cohort

artículo científico publicado en 2014

Improvements in quality of life and functional status in patients with psoriatic arthritis receiving anti-tumor necrosis factor therapies

artículo científico publicado en 2010

Infectious agents in chronic rheumatic diseases.

artículo científico publicado en 2001

Influence of anti-TNF patient warning regarding avoidance of high risk foods on rates of listeria and salmonella infections in the UK.

artículo científico publicado en 2012

Influence of anti-TNF therapy on mortality in patients with rheumatoid arthritis-associated interstitial lung disease: results from the British Society for Rheumatology Biologics Register

artículo científico publicado en 2010

Influence of anti-tumor necrosis factor therapy on cancer incidence in patients with rheumatoid arthritis who have had a prior malignancy: results from the British Society for Rheumatology Biologics Register.

artículo científico publicado en 2010

Influence of past breast feeding on pattern and severity of presentation of juvenile idiopathic arthritis

artículo científico publicado en 2015

International guidelines on access to biologic therapy: why the differences and which is best?

artículo científico publicado en 2008

Intra-articular corticosteroid injections in juvenile idiopathic arthritis

Investigating CD11c expression as a potential genomic biomarker of response to TNF inhibitor biologics in whole blood rheumatoid arthritis samples

artículo científico publicado en 2015

Investigation of genetic variants within candidate genes of the TNFRSF1B signalling pathway on the response to anti-TNF agents in a UK cohort of rheumatoid arthritis patients

artículo científico publicado en 2009

Investigation of rheumatoid arthritis susceptibility genes identifies association of AFF3 and CD226 variants with response to anti-tumour necrosis factor treatment

artículo científico publicado en 2010

Juvenile-onset inflammatory arthritis: a study of adolescents' beliefs about underlying cause

artículo científico publicado en 2012

Latent class trajectory modelling of 2-components-DAS28 identifies multiple rheumatoid arthritis phenotypes of response to biologic disease modifying anti-rheumatic drugs

artículo científico publicado en 2020

Long-Term Outcomes Following Achievement of Clinically Inactive Disease in Juvenile Idiopathic Arthritis: The Importance of Definition

artículo científico publicado en 2018

Long-term outcomes of patients who rate symptoms of rheumatoid arthritis as 'satisfactory'

artículo científico publicado en 2019

Long-term persistence of TNF-inhibitor treatment in patients with psoriatic arthritis. Data from the British Society for Rheumatology Biologics Register.

artículo científico publicado en 2018

Long-term persistence with rituximab in patients with rheumatoid arthritis. ⬇️

artículo científico publicado en 2018

Malignancy and mortality rates in patients with severe psoriatic arthritis requiring tumour-necrosis factor alpha inhibition: results from the British Society for Rheumatology Biologics Register

artículo científico publicado en 2019

Malignancy and rheumatoid arthritis: Epidemiology, risk factors and management

artículo científico publicado en 2018

Medically Significant Infections Are Increased in Patients With Juvenile Idiopathic Arthritis Treated With Etanercept: Results From the British Society for Paediatric and Adolescent Rheumatology Etanercept Cohort Study

artículo científico publicado en 2015

Melanoma risk in patients with rheumatoid arthritis treated with tumour necrosis factor alpha inhibitors: a systematic review and meta-analysis

artículo científico publicado en 2016

Methotrexate for Rheumatoid Arthritis: A Guide from Canada

article

Methotrexate persistence and adverse drug reactions in patients with juvenile idiopathic arthritis

artículo científico publicado en 2019

Mortality in patients with interstitial lung disease treated with rituximab or TNFi as a first biologic

artículo científico publicado en 2017

Mortality rates are increased in patients with systemic juvenile idiopathic arthritis.

artículo científico publicado en 2016

No evidence of association between anti-tumor necrosis factor treatment and mortality in patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register

artículo científico publicado en 2010

Not all moderate disease is the same - Identification of disability trajectories among patients with rheumatoid arthritis and moderate disease activity.

artículo científico publicado en 2019

Opportunistic infections in rheumatoid arthritis patients exposed to biologic therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.

artículo científico publicado en 2018

Outcomes after switching from one anti–tumor necrosis factor α agent to a second anti–tumor necrosis factor α agent in patients with rheumatoid arthritis: Results from a large UK national cohort study

artículo científico publicado en 2007

Outcomes of COVID-19 in patients with primary systemic vasculitis or polymyalgia rheumatica from the COVID-19 Global Rheumatology Alliance physician registry: a retrospective cohort study

artículo científico publicado en 2021

Patient global assessment in measuring disease activity in rheumatoid arthritis: a review of the literature

artículo científico publicado en 2016

Patients with suspected rheumatoid arthritis should be referred early to rheumatology

artículo científico publicado en 2008

Patterns of pain over time among children with juvenile idiopathic arthritis

artículo científico publicado en 2017

Persistence with anti-tumour necrosis factor therapies in patients with psoriatic arthritis: observational study from the British Society of Rheumatology Biologics Register

scientific article published on 08 April 2009

Pharmacogenetics of TNF inhibitor response in rheumatoid arthritis utilizing the two-component disease activity score

scientific article published on 30 October 2020

Pharmacovigilance in juvenile idiopathic arthritis patients (Pharmachild) treated with biologic agents and/or methotrexate. Consolidated baseline characteristics from Pharmachild and other national registries

artículo científico publicado en 2014

Polymorphisms spanning the TNFR2 and TACE genes do not contribute towards variable anti-TNF treatment response

artículo científico publicado en 2010

Polypharmacy is associated with treatment response and serious adverse events: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

scientific article published on 01 October 2019

Predicting Remission Remains a Challenge in Patients with Juvenile Idiopathic Arthritis

artículo científico publicado en 2019

Predicting disease outcomes in juvenile idiopathic arthritis: challenges, evidence, and new directions

scientific article published on 19 July 2019

Prediction of infection risk in rheumatoid arthritis patients treated with biologics: are we any closer to risk stratification?

artículo científico publicado en 2019

Prediction of primary non-response to methotrexate therapy using demographic, clinical and psychosocial variables: results from the UK Rheumatoid Arthritis Medication Study (RAMS).

artículo científico publicado en 2018

Prediction of response and adverse events to methotrexate treatment in patients with rheumatoid arthritis

scholarly article by Suzanne MM Verstappen et al published October 2012 in International journal of clinical rheumatology

Predictors of disability in children with inflammatory arthritis, two and three years after first presentation to paediatric rheumatology. Results from the childhood arthritis prospective study (CAPS)

Predictors of presenteeism, absenteeism and job loss in patients commencing methotrexate or biologic therapy for rheumatoid arthritis

scientific article published on 25 February 2020

Predictors of response to anti-TNF therapy in ankylosing spondylitis: results from the British Society for Rheumatology Biologics Register.

artículo científico publicado en 2009

Predictors of response to anti-TNF- therapy among patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register

article

Predictors, demographics and frequency of sustained remission and low disease activity in anti-tumour necrosis factor-treated rheumatoid arthritis patients

artículo científico publicado en 2019

Pregnancy outcome in women who were exposed to anti–tumor necrosis factor agents: Results from a national population register

scientific article published on 01 August 2006

Pregnancy outcomes in women with rheumatoid arthritis ever treated with rituximab

artículo científico publicado en 2017

Prevalence and course of lower limb disease activity and walking disability over the first 5 years of juvenile idiopathic arthritis: results from the childhood arthritis prospective study

scientific article published on 24 November 2018

Previously reported PDE3A-SLCO1C1 genetic variant does not correlate with anti-TNF response in a large UK rheumatoid arthritis cohort ⬇️

scientific article published on 16 May 2016

Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part one

article

Proceedings of the 23rd Paediatric Rheumatology European Society Congress: part two: Genoa, Italy. 28 September – 01 October 2016.

artículo científico publicado en 2017

Profiling of Gene Expression Biomarkers as a Classifier of Methotrexate Nonresponse in Patients With Rheumatoid Arthritis

scientific article published on 19 March 2019

Psychological factors predict adherence to methotrexate in rheumatoid arthritis; findings from a systematic review of rates, predictors and associations with patient-reported and clinical outcomes

artículo científico publicado en 2016

Rates of new-onset psoriasis in patients with rheumatoid arthritis receiving anti-tumour necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register.

artículo científico publicado en 2008

Rates of serious infection, including site-specific and bacterial intracellular infection, in rheumatoid arthritis patients receiving anti–tumor necrosis factor therapy: Results from the British Society for Rheumatology Biologics Register

artículo científico publicado en 2006

Real world data in rheumatology

artículo científico publicado en 2019

Recent developments in disease activity indices and outcome measures for juvenile idiopathic arthritis

artículo científico

Reconciling subject differences in recruitment to clinical trials and clinical practice

scientific article published on 01 December 2005

Reduction in the incidence of myocardial infarction in patients with rheumatoid arthritis who respond to anti-tumor necrosis factor alpha therapy: results from the British Society for Rheumatology Biologics Register

artículo científico publicado en 2007

Relationship between exposure to tumour necrosis factor inhibitor therapy and incidence and severity of myocardial infarction in patients with rheumatoid arthritis. ⬇️

artículo científico publicado en 2017

Replication of association of the PTPRC gene with response to anti-tumor necrosis factor therapy in a large UK cohort

artículo científico publicado en 2012

Reply

scholarly article by W. G. Dixon et al published 2008 in Arthritis and Rheumatism

Response to: 'Does the risk of lymphoma in patients with RA treated with TNF inhibitors differ according to the histological subtype and the type of TNF inhibitor?' by Nocturne et al.

artículo científico publicado en 2016

Response to: 'Glucocorticoid-induced relapse of COVID-19 in a patient with sarcoidosis' by Györfi et al

scientific article published on 30 June 2020

Rheumatic disease activity, glucocorticoid use and COVID-19. Response to: 'Comment on 'Characteristics associated with hospitalisation for COVID-19 in people with rheumatic disease: data from the COVID-19 Global Rheumatology Alliance physician-repor

artículo científico publicado en 2020

Rheumatic disease and COVID-19: epidemiology and outcomes

artículo científico publicado en 2020

Rheumatic disease and COVID-19: initial data from the COVID-19 Global Rheumatology Alliance provider registries

scientific article published on 16 April 2020

Rheumatoid arthritis risk allele PTPRC is also associated with response to anti-tumor necrosis factor alpha therapy

artículo científico publicado en 2010

Rheumatoid arthritis: When TNF inhibitors fail in RA--weighing up the options

artículo científico publicado en 2014

Risk mitigating behaviours in people with inflammatory skin and joint disease during the COVID-19 pandemic differ by treatment type: a cross-sectional patient survey

artículo científico publicado en 2020

Risk of Pneumocystis jirovecii pneumonia in patients with rheumatoid arthritis treated with inhibitors of tumour necrosis factor α: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.

artículo científico publicado en 2016

Risk of cancer in patients receiving non-biologic disease-modifying therapy for rheumatoid arthritis compared with the UK general population

artículo científico publicado en 2013

Risk of invasive melanoma in patients with rheumatoid arthritis treated with biologics: results from a collaborative project of 11 European biologic registers

artículo científico publicado en 2016

Risk of lymphoma in patients exposed to antitumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis

artículo científico publicado en 2016

Risk of septic arthritis in patients with rheumatoid arthritis and the effect of anti-TNF therapy: results from the British Society for Rheumatology Biologics Register

artículo científico publicado en 2011

Risk of skin and soft tissue infections (including shingles) in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register

artículo científico publicado en 2012

Risk of solid cancer in patients exposed to anti-tumour necrosis factor therapy: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.

artículo científico publicado en 2014

Rituximab or a second anti-tumor necrosis factor therapy for rheumatoid arthritis patients who have failed their first anti-tumor necrosis factor therapy? Comparative analysis from the British Society for Rheumatology Biologics Register.

artículo científico publicado en 2012

SARS-CoV-2 breakthrough infections among vaccinated individuals with rheumatic disease: results from the COVID-19 Global Rheumatology Alliance provider registry

artículo científico publicado en 2022

SAT0359 Aligning Clinical Trials in Rheumatoid Arthritis with Real-Life Populations ⬇️

scholarly article by N.C. Navarro Coy et al published June 2015 in Annals of the Rheumatic Diseases

Serious infection across biologic-treated patients with rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.

artículo científico publicado en 2018

Serious infection following anti-tumor necrosis factor alpha therapy in patients with rheumatoid arthritis: lessons from interpreting data from observational studies.

artículo científico publicado en 2007

Serious infection risk after 1 year between patients with rheumatoid arthritis treated with rituximab or with a second TNFi after initial TNFi failure: results from The British Society for Rheumatology Biologics Register for Rheumatoid Arthritis.

artículo científico publicado en 2017

Short-term outcomes in patients with systemic juvenile idiopathic arthritis treated with either tocilizumab or anakinra

artículo científico publicado en 2019

Spectrum of lymphomas across different drug treatment groups in rheumatoid arthritis: a European registries collaborative project.

artículo científico publicado en 2017

Testing the role of vitamin D in response to antitumour necrosis factor α therapy in a UK cohort: a Mendelian randomisation approach

artículo científico publicado en 2013

The BSRBR-RA at 15 years

artículo científico publicado en 2016

The British Society for Rheumatology Biologics Register: 6 years on

artículo científico publicado en 2008

The EULAR Study Group for Registers and Observational Drug Studies: comparability of the patient case mix in the European biologic disease modifying anti-rheumatic drug registers

artículo científico publicado en 2014

The Role of Anti–Tumor Necrosis Factor Receptor Agents in Cancer Survivors: Does the Risk Justify the Benefit?

scientific article published on 01 February 2010

The association between low socioeconomic status with high physical limitations and low illness self-perception in patients with juvenile idiopathic arthritis: results from the Childhood Arthritis Prospective Study.

artículo científico publicado en 2015

The incidence of cancer in patients with rheumatoid arthritis and a prior malignancy who receive TNF inhibitors or rituximab: results from the British Society for Rheumatology Biologics Register-Rheumatoid Arthritis ⬇️

artículo científico publicado en 2016

The incidence of rheumatoid arthritis in the UK: comparisons using the 2010 ACR/EULAR classification criteria and the 1987 ACR classification criteria. Results from the Norfolk Arthritis Register

artículo científico publicado en 2012

The influence of TNF inhibitors on dementia incidence in patients with rheumatoid arthritis; an analysis from the BSRBR-RA.

artículo científico publicado en 2018

The influence of anti-TNF therapy upon incidence of keratinocyte skin cancer in patients with rheumatoid arthritis: longitudinal results from the British Society for Rheumatology Biologics Register

artículo científico publicado en 2012

The influence of behavioural and psychological factors on medication adherence over time in rheumatoid arthritis patients: a study in the biologics era.

artículo científico publicado en 2015

The predictive value of serum S100A9 and response to etanercept is not confirmed in a large UK rheumatoid arthritis cohort ⬇️

artículo científico publicado en 2017

The predictors of and reasons for non-adherence in an observational cohort of patients with rheumatoid arthritis commencing methotrexate

artículo científico publicado en 2020

The prioritization of symptom beliefs over illness beliefs: The development and validation of the Pain Perception Questionnaire for Young People

artículo científico publicado en 2017

The relationship between depression and biologic treatment response in rheumatoid arthritis: An analysis of the British Society for Rheumatology Biologics Register

artículo científico publicado en 2018

The risk of gastrointestinal perforations in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the BSRBR-RA.

artículo científico publicado en 2013

The risk of serious infections in patients receiving anakinra for rheumatoid arthritis: results from the British Society for Rheumatology Biologics Register

artículo científico publicado en 2011

The risk of uveitis in patients with JIA receiving etanercept: the challenges of analysing real-world data

scientific article published on 12 October 2019

The role of the British Society for Rheumatology Biologics Register (BSRBR) and the NICE guidelines for anti-TNF therapy

artículo científico publicado en 2003

Translating research into clinical practice: quality improvement to halve non-adherence to methotrexate

artículo científico publicado en 2020

Treatment prescribing patterns in a cohort of patients with juvenile idiopathic arthritis (JIA). Data from the childhood arthritis prospective study (CAPS).

artículo científico publicado en 2014

Treatment prescribing patterns in patients with juvenile idiopathic arthritis (JIA): Analysis from the UK Childhood Arthritis Prospective Study (CAPS).

artículo científico publicado en 2016

Trends in paediatric rheumatology referral times and disease activity indices over a ten-year period among children and young people with Juvenile Idiopathic Arthritis: results from the childhood arthritis prospective Study

artículo científico publicado en 2016

Trends in paediatric rheumatology referral times and disease activity indices over a ten-year period among children with juvenile idiopathic arthritis: results from the childhood arthritis prospective study.

artículo científico publicado en 2014

Understanding Refractory Rheumatoid Arthritis: Implications for a Therapeutic Approach

scientific article published on 02 May 2020

Update on the epidemiology, risk factors and disease outcomes of Juvenile idiopathic arthritis

artículo científico publicado en 2018

Use and effectiveness of rituximab in children and young people with juvenile idiopathic arthritis in a cohort study in the United Kingdom

artículo científico publicado en 2019

Use and effectiveness of tocilizumab among patients with rheumatoid arthritis: an observational study from the British Society for Rheumatology Biologics Register for rheumatoid arthritis

artículo científico publicado en 2016

Validity of a three-variable Juvenile Arthritis Disease Activity Score in children with new-onset juvenile idiopathic arthritis

artículo científico publicado en 2012

Venous thrombotic events are not increased in patients with rheumatoid arthritis treated with anti-TNF therapy: results from the British Society for Rheumatology Biologics Register.

artículo científico publicado en 2011

What can rheumatology expect from real-world data?

artículo científico publicado en 2020

What is the impact of biologic therapies on common co-morbidities in patients with rheumatoid arthritis?

artículo científico publicado en 2016

Why do the French get much greater access to anti-TNF than the British? Vive la difference? Pas necessairement

artículo científico publicado en 2008

Working status in patients with rheumatoid arthritis, ankylosing spondylitis and psoriatic arthritis: results from the British Society for Rheumatology Biologics Register.

artículo científico publicado en 2010

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda